Focal Therapeutics products and/or their use may be covered by one or more U.S. and/or foreign patents:
US 6,161,034; US 6,427,081; US 8,288,745; US 8,541,764; US 9,014,787; US 9,199,092; US 9,615,915; US 9,980,809.
Other patent applications are pending. This page is intended to serve as notice under 35 U.S.C. §287(a). BioZorb and Focal Therapeutics are registered trademarks of Focal Therapeutics. All rights reserved.